Pharma Industry News Archive

Pharma Industry News: November 2008

November 3 Over 60 Million U.S. Adults Engaging in Health 2.0
November 3 Tweens and Teens Double Use of Diabetes Drugs
November 3 Daiichi Sankyo Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey
November 3 Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
November 3 Avigen Announces Restructuring and Strategic Direction
November 4 John Patterson to Retire from AstraZeneca
November 4 Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products
November 4 Replidyne and Cardiovascular Systems Sign Merger Agreement
November 4 Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra and Launches Immediately
November 5 Westaim Terminates Reorganization Agreement and Cancels Shareholders' Meeting
November 5 Drug Companies Gave Vermont Health Care Providers Gifts Worth $4.9 Million Over Two Years
November 5 Grassley Calls on FDA Leaders to Address Mismanagement of FDA Employee Pay and Benefits
November 5 Hospira Reports Third-Quarter 2008 Results
November 5 ImClone Systems Announces Expiration of Hart-Scott-Rodino Waiting Period
November 5 Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
November 5 Urigen Outlines Operating Plans
November 6 FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes
November 6 King Pharmaceuticals Reports Third-Quarter 2008 Financial Results
November 6 Pfizer Discontinues Development Program for Its Phase 3 Obesity Compound (CP-945,598)
November 6 Teva Reports Third Quarter 2008 Results
November 6 Devgen announces the intention to close its pharma division and to fully focus on the development of its agro business
November 6 Sanofi-aventis to Discontinue all Clinical Trials with rimonabant
November 6 Teva Updates 2008 Financial Outlook
November 7 FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
November 7 Express Scripts Warns of Potential Large Data Breach Tied to Threat
November 7 Novo Nordisk Invests Close to 400 Million US Dollars in New Insulin Production Plant in China
November 7 Amgen Positioned to Deliver Attractive Growth Over Next Five Years
November 7 CHI Congratulates Congressional Election Winners
November 10 Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b Vaccine) Available in Japan on December 19, 2008
November 10 Crestor Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
November 10 Biovest International Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize its Drugs and Technologies
November 11 Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
November 11 Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
November 11 ASI Announces Results of Advertising Specialties Impression Study
November 11 New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
November 12 Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants
November 12 GeneNews Restructures Operations
November 12 FDA Approves 30-Minute Onset of Action for Focalin XR
November 12 Express Scripts Reports New Threats Tied to Data Security Breach
November 12 GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.
November 13 FDA Updates the Early Communication about the Ongoing Safety Review of Bisphosphonates
November 13 FDA Warns Public of Extortion Scam by FDA Impersonators
November 13 Pharmaceutical Industry Needs To Speed Up Transformation To Meet Changing Market Dynamics, According To Ernst & Young Report
November 13 FDA Warns Public of Extortion Scam by FDA Impersonators
November 13 FDA MedWatch- Bisphosphonates-Update To The Early Communication Issued Regarding Atrial Fibrillation With Bisphosphonates
November 13 Public Statement On Exubera (Insulin Human) Withdrawal Of The Marketing Authorisation In The European Union
November 13 Novo Nordisk Launches Levemir Satisfaction Guarantee Program
November 14 Actavis Comments on Filing of DOJ Complaint
November 14 Pfizer Launches Global Regenerative Medicine Research Unit
November 14 Valeant Pharmaceuticals Acquires DermaTech
November 14 Senate Finance Chairman Baucus Unveils Blueprint for Comprehensive Health Care Reform
November 14 The U.S. Remains Preferred Market for Launching New Products
November 14 Javelin Pharmaceuticals Announces 15 Percent Reduction in Workforce
November 17 Roche, Merck Serono and Abbott Join Forces in Biotechnology Cluster Rhine-Neckar (BioRN)
November 17 FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder
November 17 Out-of-Pocket Costs Grow in Medicare Part D
November 17 FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint
November 17 Solvay Pharmaceuticals Discontinues R&D Activities of its Anti-Obesity Compound SLV319
November 17 Progenics Announces Wyeth Has Received Relistor Approval in Australia
November 17 BioSante Pharmaceuticals Announces Receipt of NIH Grant for Inhaled Interferon
November 17 Mortara Instrument Announces Extension of ECG Warehouse CRADA With US FDA
November 18 ImClone Systems Announces Clearance of Tender Offer by German FederalCartel Office
November 18 Genentech Issues Dear Healthcare Provider Letter Regarding a2nd Case of PML in a Raptiva Patient
November 18 ACI’s FDA Boot Camp is the industry standard in providing non-regulatory professionals with the regulatory foundation critical to success
November 18 Manhattan Research Releases Report on the Future of Physician Customer Service Portals
November 18 AstraZeneca Appoints Rich Fante as President of its U.S. Business
November 18 I'm Sticking With My Brand: Loyal Customers Perceive Competitor Ads Differently
November 18 Study Finds Cost of Diabetes in the United States Exceeds $217 Billion
November 18 Sanofi-Aventis Pharma S.A. Withdraws Its Application for an Extension of Indication for Taxotere and Docetaxel Winthrop (docetaxel)
November 18 Public Statement on Forcaltonin - Withdrawal of the Marketing Authorisation in the European Union
November 18 Telephone Counseling May Improve Effectiveness of Varenicline (Chantix), According to Free & Clear Study
November 18 ACP Guideline Finds No Substantial Differences Among “Second-Generation” Antidepressants
November 19 Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline
November 19 Barr Announces Agreements on Nasacort AQ, Allegra D-12 and Allegra Patent Challenges
November 19 ADHD Medications Do Not Cause Genetic Damage In Children
November 19 Teva Receives First U.S. Approval for Generic Pulmicort Respules;Commences Commercial Launch
November 19 Widely-Used Cancer Drug Associated With Significantly Increased Risk of Blood Clots
November 19 Prescription Project Welcomes U.S. Appeals Court Ruling in “Data-Mining” Case
November 19 Nevada Attorney General Cortez Masto Files Suit Against Hormone Therapy Drug Manufacturers
November 19 IMS v. Ayotte - Physician Privacy Law Upheld as Constitutional by First Circuit
November 19 Media Statement re: New Hampshire's Decision to Overturn a New Hampshire U.S. District Court Ruling that Struck Down the State’s Law Banning the Commercial Use of Prescriber-Identifiable Data
November 19 AstraZeneca Enters Agreement for Authorized Generic Pulmicort Respules
November 19 WebMD and Marketing Technology Solutions Terminate Merger Agreement
November 19 Ambrilia Initiates Plan Aiming to Significantly Reduce its Operations in France
November 19 Orion to Renew Operational Model of Pharmaceutical R&D. Negotiation Proposal on Reduction of up to 300 Employees in Finland
November 20 Pfizer Withdraws Application to Switch Viagra to Non-PrescriptionStatus in Europe
November 20 BIO Congratulates Former Senator Tom Daschle on His Nomination toServe as HHS Secretary
November 20 ImClone Systems' State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production
November 20 FDA Advisory Committee Provides Opinion on Oritavancin for theTreatment of Complicated Skin and Skin Structure Infections
November 20 AstraZeneca to Realign Supply Chain to Improve Productivity and Move Closer to Customers
November 20 Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
November 20 AstraZeneca Granted Temporary Restraining Order in Pulmicort Respules Patent Litigation
November 20 New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
November 20 Cervarix, GSK’s Cervical Cancer Vaccine, Wins Tender for Dutch National Immunisation Programme
November 20 FDA Sends Warning Letter to Shionogi Over Cedax Direct Mailers
November 20 European Medicines Agency Recommends the Suspension of the Marketing Authorisation of Ionsys (fentanyl hydrochloride)
November 20 FDA Sends Letter to Protherics Over Voraxaze Web Material
November 20 Internet Advertising Revenues in Q3 ’08 at Nearly $5.9 Billion
November 21 Vical Announces Strategic Restructuring and Staff Reduction
November 21 SurModics Announces Changes to Its Organizational Structure and Cost-Cutting Initiatives
November 21 Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension
November 21 CombinatoRx Concentrates on Core Strengths
November 21 Lilly Completes Cash Tender Offer for ImClone Systems
November 21 Nplate (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
November 21 MINRAD International, Inc. Announces Reduction in Workforce
November 21 CHMP Posts 12 Opinions
November 21 Physicians Anticipate Higher Prescribing Based on JUPITER Study
November 21 Barr Shareholders Approve Pending Teva Acquisition
November 21 New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
November 24 Labopharm's NDA for Novel Trazodone Formulation Accepted for Review by FDA
November 24 Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
November 24 PhRMA Statement on New National Advertising Campaign
November 24 King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
November 24 FDA Extends Review of Somaxon Pharmaceuticals' New Drug Application for Silenor (Doxepin) by up to Three Months
November 24 XDx Announces Strategic Restructuring
November 24 Lilly Completes Acquisition of ImClone Systems
November 24 Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
November 24 Genzyme Seeks U.S. Approval for Clolar to Treat Adult AML
November 25 AstraZeneca Provides Update on Agreement with Abraxis Biosciences for Co-Promotion of Abraxane in the US
November 25 Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
November 25 Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
November 25 Antitrust: European Commission Confirms Unannounced Inspections at Pharmaceutical Companies
November 25 Anika Therapeutics Terminates Contract with U.S. Distribution Partner for ELEVESS
November 25 Bayer Healthcare to Pay U.S. $97.5 Million to Settle Allegations of Paying Kickbacks to Diabetic Suppliers
November 25 Bayer Healthcare llc Reaches Settlement with U.S. Department of Justice on Investigation into former Diabetes Care Marketing Programs
November 26 FDA Sends Warning Letter to Actelion Over Tracleer Flash Card
November 26 Use Of Inhaled Corticosteroids For Copd Does Not Appear To Improve Survival, But May Increase Risk For Pneumonia
November 26 FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
November 26 Pfizer's Novel HIV/AIDS Treatment Selzentry Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients
November 26 Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
November 26 Growth hormone not beneficial for ALS

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web4)